- A 30-Minute Endometriosis
Test*
- Instant Results
- Highly Accurate
- Non-Invasive
- Diagnose Endo at All Stages
- Supports Highly Accurate
Rapid Diagnosis² ³
- Diagnose Endo at All Stages
- A 30-Minute Endometriosis Test
- Instant Results
- Highly Accurate
- Non-Invasive
- Diagnose Endo at All Stages
Women worldwide suffer for an average of 8.6 years before being diagnosed with endometriosis.⁴ Leading the charge to change this, the EndoSure Test* takes 30 minutes and provides physicians with simple, objective data to support a rapid diagnosis of endometriosis.
Endometriosis is a debilitating disease that effects over 10% of women globally. As a clinical decision support tool the
EndoSure
Test* is the only noninvasive, 30-minute, objective test to help physicians quickly and accurately diagnose endometriosis regardless of disease stage. The test is a game changer in how physicians diagnose endometriosis, and can be used during the initial encounter for patients presenting with pelvic or menstrual pain and for those requiring post-treatment monitoring.
Now Women Can Be Sure
Facilitating a diagnosis of endometriosis is now as easy as 1-2-3
The Only Non-Invasive, 30-Minute Clinical Decision Support Tool supporting the Highly Accurate and Rapid Diagnosis of Endometriosis.² ³
The EndoSure Test* has a number of advantages:
and Routine Screening
The EndoSure Test* is a Non-Invasive, 30 Minute Clinical Decision Support Tool that uses myoelectrical data that comes from an Electrogastrogram (EGG)/Electroviscerogram (EVG). An EGG/EVG is a simple non-invasive, painless procedure performed by utilizing topical electrode pads similar to those used in an electrocardiogram (ECG) to measure the myoelectrical activity of the smooth muscle of the GI tract. The EndoSure Test* support software performs calculations using the collected EGG/EVG data. These calculations, which are based on published research³, support a physician’s utility of the data to support the diagnosis of endometriosis.
Published data³ has demonstrated that the EndoSure Test* can support an accurate diagnosis of endometriosis 98-99% of the time (as confirmed by surgical findings):
Prior to arriving to the clinic for the test you will need to fast for 6 - 8 hours. Once there, you will be seated in a comfortable, reclining chair. While you are in a reclining position, the technician will place a flexible respiratory belt across your upper chest over your garments, and three electrode pads on your abdomen.
You will then be asked to hold still for 10 minutes during which time a baseline recording is obtained. At this point, you will then be asked to drink water until you feel full. You will have five minutes to drink the water. For the remainder of the test, you will be asked to sit still in the reclining position for an additional 30 minutes. There is no discomfort or danger associated with this test.
No. The practitioner will need to fix the sensors just above your umbillicus, or belly button, and so your upper garment will be lifted exposing the area to the rib cage.
The test itself is completed within 30 mins. Before the test there is a short patient preparation time.
The results are available to your physician as soon as the test is completed. Generally, your physician will need to review and analyze the results along with other medical findings before reviewing with you.
About Us
EndoSure offers the only non-invasive, 30-minute test to support the diagnosis of endometriosis that not only fills the gap, but addresses the vacuum in this area of women’s health care.*
© July 2024 ENDOSURE, Inc. All rights reserved
site design by
Boston Web Partners
Contact Information
954 Ridgebrook Road
Sparks Glencoe, Maryland 21152
1. Approximately 15-20 minutes of patient preparation time may be required prior to performing the test.
2. Mathias JR, Franklin R, Quast DC, Fraga N, Loftin CA, Yates L, Harrison V. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81-8.
3. i. Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024 May 13;13(10):2866. doi: 10.3390/jcm13102866. PMID: 38792407; PMCID: PMC11122642.
4. Zondervan, K.T.; Becker, C.M.; Koga, K.; Missmer, S.A.; Taylor, R.N.; Viganò, P. Endometriosis. Nat. Rev. Dis. Primers. 2018:4-9.
5. 1. Noar M, Mathias J, Kolatkar A. Validation of New GIMA Biomarker Signature of Endometriosis - Interim Data: Research Article. TechRxiv. August 26, 2024. DOI: 10.22541/au.172469630.08159498/v1
6. 1. Kitsantas P, Benson KN, Al-Farauki S, Knecht MK, Hennekens CH, et al. (2024) Emerging Diagnostic Tools for the Early Diagnosis of Endometriosis. J Reprod Med Gynecol Obstet 9: 171.
DISCLAIMER: THE ENDOSURE TEST IS A CLINICAL DECISION SUPPORT TOOL INTENDED TO INFORM AND ENHANCE A HEALTHCARE PROVIDER'S DECISION-MAKING PROCESS, WHICH MUST BE INDIVIDUALIZED FOR EACH PATIENT'S CIRCUMSTANCES AND TAKE INTO ACCOUNT THE FULL SCOPE OF MEDICAL DATA AND INFORMATION AVAILABLE TO THE PROVIDER. THE ENDOSURE TEST IS NOT INTENDED TO SUBSTITUTE, REPLACE, OVERRULE, OR DIRECT A HEALTHCARE PROVIDER’S JUDGMENT.
443-391-7500
* US CUSTOMERS: Endosure is currently available for research use only and not clinical use.